9 results
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
to our product candidates. Such events could subject us to costly litigation, require us to pay substantial amounts of money to injured patients
20-F
2020 FY
IMCR
Immunocore Holdings plc
25 Mar 21
Annual report (foreign)
7:01am
substantial amounts of money to injured patients, delay, negatively impact or end our opportunity to receive or maintain regulatory approval to market our
424B4
IMCR
Immunocore Holdings plc
8 Feb 21
Prospectus supplement with pricing info
8:36am
product candidates. Such events could subject us to costly litigation, require us to pay substantial amounts of money to injured patients, delay
F-1/A
IMCR
Immunocore Holdings plc
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
be related to our product candidates. Such events could subject us to costly litigation, require us to pay substantial amounts of money to injured
F-1/A
5l0 y2bdx
1 Feb 21
Registration statement (foreign) (amended)
6:21am
F-1
ks9re7f azaq
15 Jan 21
Registration statement (foreign)
4:57pm
DRS/A
rol 6tw1upf
19 Nov 20
Draft registration statement (amended)
12:00am
DRS
nms1akvhisb
17 Nov 20
Draft registration statement
12:00am
- Prev
- 1
- Next